Overview
- Legal name
- NEW YORK GENOME CENTER, INC.
- Registered location
- NEW YORK, NY, USA
- Website
- Company website ↗
- Primary NAICS
- 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
- Latest award activity
- Aug 11, 2026
Read company summary
NEW YORK GENOME CENTER, INC. is associated with UEI WKPTJDWG2C68 and CAGE 5P5D4 in public federal records. AcornBids currently links 14 prime awards totaling $37.7M in obligations to this entity. Its largest recorded federal customer by obligations is Department of Health and Human Services. Its recorded federal awards include work classified as Research and Development in Biotechnology (except Nanobiotechnology); Testing Laboratories and Services; All Other Professional, Scientific, and Technical Services. These categories describe the loaded award records, not a complete list of company capabilities. Its primary SAM.gov NAICS is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)). Its public SAM.gov registration lists NEW YORK, NY, USA.
At a glance
Not available
Why this customer concentration
Detailed agency totals are not available in this stored profile.
Largest positive coded-agency total ÷ all positive coded-agency totals × 100
Missing data is shown as unavailable.
Prime contract obligations across loaded award records. Obligations are not revenue or contract ceilings. Summary updated Oct 7, 2026. Refresh pending; these totals may be out of date.
Business information
Public SAM.gov registration details.
- Legal name
- NEW YORK GENOME CENTER, INC.
- UEI
- WKPTJDWG2C68
- CAGE
- 5P5D4
- Registered address
- 101 AVENUE OF THE AMERICAS FL 7, NEW YORK, NY, 10013, USA
- Registration status
- Active
- Primary NAICS
- 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
- SAM activation
- Nov 11, 2025
- Initial registration
- Jul 17, 2012
- Entity start
- Aug 5, 2010
- SAM updated
- Nov 11, 2025
- Registration expires
- Nov 7, 2026
- Fiscal year end
- Dec 31
- Place of incorporation
- DE, USA
Research brief
Source facts
- Loaded prime-award records link 14 awards and $37,729,599 in reported obligations to this legal entity. Source
- Recorded awards include Research and Development in Biotechnology (except Nanobiotechnology) (NAICS 541714); this classification is not proof of every company capability. Source
- An example award describes: NHLBI TRANS-OMICS FOR PRECISION MEDICINE (TOPMED) FOR THE CENTRALIZED OMICS RESOURCE (CORE) - RNA-SEQ Source
Federal award analysis
Net transaction obligations by federal fiscal period.
Reported transaction obligations by federal fiscal period; includes deobligations. Missing transactions are not estimated. Coverage: 14 of 14 selected awards. Select a period to explore its awards.
Recent federal awards
Prime contract awards. Select an award to review its history and source evidence.
| Award / description | Awarding agency | Obligations | Start date | End date |
|---|---|---|---|---|
| 75N92023F00002NHLBI TRANS-OMICS FOR PRECISION MEDICINE (TOPMED) FOR THE CENTRALIZED OMICS RESOURCE (CORE) - RNA-SEQ | Department of Health and Human Services | $742.4K | Sep 28, 2023 | Sep 27, 2027 |
| 75N92024F00001NHLBI TRANS-OMICS FOR PRECISION MEDICINE (TOPMED) FOR THE CENTRALIZED OMICS RESOURCE (CORE) - RNA-SEQ - 2024 TASK ORDER | Department of Health and Human Services | $5.7M | Sep 23, 2024 | Sep 22, 2027 |
| 75N92025F00001NHLBI TRANS-OMICS FOR PRECISION MEDICINE (TOPMED) FOR THE CENTRALIZED OMICS RESOURCE (CORE) | Department of Health and Human Services | $1.9M | Sep 23, 2025 | Sep 22, 2027 |
| 75N95023F00002UNSPECIFIED [23-005143] | Department of Health and Human Services | $22.7M | May 29, 2023 | May 28, 2027 |
| 36C24E26N0114NEXT GENERATION SEQUENCING FOR ON-GOING RESEARCH STUDY | Department of Veterans Affairs | $19.6K | Jun 1, 2026 | May 31, 2027 |
| 36C24E26P0011RNA SEQUENCING SERVICES (RESEARCH STUDY SUPPORT) | Department of Veterans Affairs | $130.5K | Apr 22, 2026 | Apr 21, 2027 |
| 36C24E23N0010NEXT GENERATION SEQUENCING SERVICES FOR ON-GOING RESEARCH STUDY | Department of Veterans Affairs | $82.5K | Dec 5, 2022 | Dec 4, 2023 |
| 36C24E20P0236GENOME SEQUENCING TO SUPPORT RESEARCH | Department of Veterans Affairs | $89.3K | Sep 23, 2020 | Dec 31, 2021 |
| 36C24E25N0039NEXT GENERATION SEQUENCING FOR ON-GOING RESEARCH STUDY | Department of Veterans Affairs | $26.0K | Dec 1, 2024 | Nov 30, 2025 |
| 75N91020F00001DNA METHYLATION ARRAYS FOR NEW CCG STUDIES PERIOD OF PERFORMANCE 09/02/2020 - 09/01/2023 FULLY FUNDED, NON-SEVERABLE, FIXED PRICE TASK ORDER | Department of Health and Human Services | $274.0K | Sep 2, 2020 | Apr 24, 2025 |
Upcoming positioning windows
Modeled recompete windows are estimates, not announced solicitations or guarantees.
Registration, certifications & contacts
| Registration evidence | Date |
|---|---|
| SAM updated | Nov 11, 2025 |
| Source loaded | Sep 26, 2026 |
| Initial registration | Jul 17, 2012 |
| Entity start | Aug 5, 2010 |
| Industry | Reported size status |
|---|---|
| 541380 — Testing Laboratories and Services | Not reported |
| 541714 — Research and Development in Biotechnology (except Nanobiotechnology) | Not reported |
| 541990 — All Other Professional, Scientific, and Technical Services | Not reported |
| 621511 — Medical Laboratories | Not reported |
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| HEATHER G LEWIS | Government business | Contact method not published | SAM registration | Not available |
| ELIZABETH O'BRIEN | Alternate government business | Contact method not published | SAM registration | Not available |
| HEATHER G LEWIS | Electronic business | Contact method not published | SAM registration | Not available |
Registered industries
- 541380 — Testing Laboratories and Services
- 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
- 541990 — All Other Professional, Scientific, and Technical Services
- 621511 — Medical Laboratories
Registration classifications and published certificates do not by themselves establish eligibility for a particular solicitation. View SAM source
Related companies worth researching
Explore the customer, work and award-size evidence behind each match.
About NEW YORK GENOME CENTER, INC.
What products and services appear in its federal awards?
Recorded award industries: 541714 — Research and Development in Biotechnology (except Nanobiotechnology); 541380 — Testing Laboratories and Services; 541990 — All Other Professional, Scientific, and Technical Services.
Recorded products and services: AN11 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH; B599 — Other Special Studies and Analysis; B529 — Scientific Data Studies.
Examples from recent award records:
- NHLBI TRANS-OMICS FOR PRECISION MEDICINE (TOPMED) FOR THE CENTRALIZED OMICS RESOURCE (CORE) - RNA-SEQ
- NHLBI TRANS-OMICS FOR PRECISION MEDICINE (TOPMED) FOR THE CENTRALIZED OMICS RESOURCE (CORE) - RNA-SEQ - 2024 TASK ORDER
These records describe federal award work, not every company capability. Review the award evidence.
Where is the company registered?
101 AVENUE OF THE AMERICAS FL 7, NEW YORK, New York 10013, United States
Registered location from SAM.gov; award performance locations may differ.
What is its primary registered industry?
541714 — Research and Development in Biotechnology (except Nanobiotechnology).
Primary SAM.gov NAICS classification.
Which federal agencies are represented in its awards?
Department of Health and Human Services; Department of Veterans Affairs.
Data coverage and methodology
Sources: SAM.gov registration, USAspending awards and transactions, and linked supporting records. Prime contract obligations, IDV ceilings and assistance amounts are kept separate. Missing records are not zero activity. Company claims are labeled separately. Recompete signals are rule-based scores out of 100. Positioning windows are AcornBids estimates.
Disclosed relationships only. Missing records do not establish that a contractor has no partners. Ambiguous parent award identifiers are excluded.
Recently viewed companies
Keep your research moving
Save this company, track changes, and evaluate upcoming work against your targets.
Save to my research Find my fit